Nitric oxide and cell death in liver cancer cells

Jordi Muntané1, Angel J De la Rosa, Luís M Marín

  • 1Oncology Surgery, Cell Therapy and Transplant Organs, Instituto de Biomedicina de Sevilla (IBiS)/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain. jmuntane-ibis@us.es

Mitochondrion
|September 27, 2012
PubMed

Insights

Nitric oxide (NO) regulates cellular responses and impacts cancer development. This study explores NO's role in sensitizing hepatoma cells to chemotherapy, potentially via p53 and death receptor pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Nitric oxide (NO) is a crucial physiological messenger involved in various cellular processes.
  • NO mediates its effects through cGMP-dependent and independent pathways, including post-translational modifications.
  • The impact of NO in cancer is complex, influenced by NOS isoform activity, NO concentration, duration, and cellular context.

Purpose of the Study:

  • To investigate the role of nitric oxide in cancer, specifically its effects on hepatoma cells.
  • To elucidate the mechanisms by which NO influences cellular responses, including growth arrest, apoptosis, and adaptation.
  • To determine if NO can sensitize hepatoma cells to chemotherapeutic agents.

Main Methods:

  • Analysis of nitric oxide signaling pathways.
  • Investigation of NO's interaction with key regulatory factors like hypoxia-inducible factor-1 (HIF-1) and p53.
  • Assessment of NO's effect on hepatoma cell sensitivity to chemotherapy.

Main Results:

  • Nitric oxide regulates critical factors such as HIF-1 and p53, influencing cell fate.
  • NO exposure can lead to growth arrest, apoptosis, or cellular adaptation.
  • Nitric oxide demonstrated potential in sensitizing hepatoma cells to chemotherapeutic compounds.

Conclusions:

  • Nitric oxide plays a multifaceted role in cancer biology.
  • NO-mediated sensitization of hepatoma cells to chemotherapy may involve upregulation of p53 and cell death receptors.
  • Further research into NO-based therapeutic strategies for cancer is warranted.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...